J. Vázquez

Successful Optimization of Adalimumab Therapy in Refractory Uveitis Due to Behçet's Disease.

M. González-Gay, J. Nolla, J. Callejas-Rubio, 2018, Ophthalmology.

Anti-TNF-α therapy in patients with refractory uveitis due to Behçet's disease: a 1-year follow-up study of 124 patients.

F. Romero-Bueno, S. Muñoz Fernández, E. Pato, 2014, Rheumatology.

Comparative Study of Infliximab Versus Adalimumab in Refractory Uveitis due to Behçet's Disease: National Multicenter Study of 177 Cases

M. González-Gay, J. Nolla, E. M. Muro, 2019, Arthritis & rheumatology.

FRI0269 COMPARATIVE STUDY OF INFLIXIMAB VERSUS ADALIMUMAB IN REFRACTORY UVEITIS DUE TO BEHÇET’S DISEASE. NATIONAL MULTICENTER STUDY OF 177 CASES

F. Romero, J. Nolla, S. Castañeda, 2019, Poster Presentations.

Long-term outcomes in patients with schizophrenia treated with risperidone long-acting injection or oral antipsychotics in Spain: Results from the electronic Schizophrenia Treatment Adherence Registry (e-STAR)

C. Rojo, M. Sacristán, L. Sans, 2009, European Psychiatry.